- Nachrichtendetail
-
26.07.2024 14:47:13 - dpa-AFX: *CHMP RECOMMENDS J&J'S RYBREVANT WITH CHEMO FOR ADVANCED EGFR-MUTATED NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Frankfurt | 134,140 | 14.07.25 16:26:45 | +1,520 | +1,15% | 0,000 | 0,000 | 134,360 | 132,620 |
